FDA Expands Approval of Chemo-Free Bladder Cancer Combo in Curative Setting
(MedPage Today) -- The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with enfortumab vedotin (Padcev) as perioperative treatment for…
Read the full article11h agoen
You might also wanna read
King's College London study identifies novel mechanism of brain cell death in Alzheimer's disease
sciencealert.com·15m ago
Dementia rates among elderly Americans are declining, research shows
economist.com·1h ago
How extreme heat impairs cognitive function and mental health: What researchers know so far
technologyreview.com·1h ago
NPPA announces price cap on 30 medicines including diabetes, hypertension and cardiac drugs; check full list here
news9live.com·1h ago
Putney Leisure Centre’s new survey doesn’t ask about the pool
Putney·1h ago
Vape Pilleri Sıcak Hava Riski Taşıyor
sondakika.com·2h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.